Product Information
CHEST CONGESTION RELIEF SOLN is a generic product labeled by Rugby Laboratories, priced at $0.0110 per ML under NDC 00536131485. Its NADAC has been published 307 times since Nov 18, 2020.
Strength
100 mg/5mL
Manufacturer
Rugby LaboratoriesNDC
00536131485
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/1/2020
Pharmacological Classes
Price Statistics
The NADAC for CHEST CONGESTION RELIEF SOLN has been published 307 times since Nov 18, 2020, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0110 per ML |
|---|---|
| All-time high | $0.0154 (Feb 10, 2021) |
| All-time low | $0.0089 (Jul 17, 2024) |
| 52-week high | $0.0138 |
| 52-week low | $0.0110 |
| Median price | $0.0121 |
| Average price | $0.0119 |
| Largest weekly change | +40.8% (Jun 23, 2021) |
| Weeks tracked | 307 |
| Tracking since | Nov 18, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHEST CONGESTION RELIEF SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CHEST CONGESTION RELIEF SOLN, manufactured by Rugby Laboratories, is $0.0110 per ML (NDC 00536131485), effective Sep 30, 2026.
How has the price of CHEST CONGESTION RELIEF SOLN changed over time?
Over the history we have for it, the NADAC for CHEST CONGESTION RELIEF SOLN has declined 9.3%. It has been tracked across 307 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for CHEST CONGESTION RELIEF SOLN?
Since Nov 18, 2020, the NADAC for CHEST CONGESTION RELIEF SOLN has ranged from a low of $0.0089 (Jul 17, 2024) to a high of $0.0154 (Feb 10, 2021), with a median of $0.0121 per ML.
Are there cheaper alternatives to CHEST CONGESTION RELIEF SOLN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHEST CONGESTION RELIEF SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures CHEST CONGESTION RELIEF SOLN?
CHEST CONGESTION RELIEF SOLN (NDC 00536131485) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.